Annexin I has been implicated in the regulation of phagocytosis, cell signaling and cell proliferation
| Institute |
|---|
| University College London (UCL) |
| Cat. #: | 151207 |
|---|---|
| Unit size: | 100 ug |
| Research Fields: | Apoptosis and autophagy;Biochemistry;Cell biology;Cell signaling and signal transduction;Tissue-specific biology |
| Application: | ELISA ; IHC ; IF ; WB |
| Target: | Annexin I |
| Reactivity: | Human |
| Clone: | ANEX 6E4/3 |
| Host: | Mouse |
| Class: | Monoclonal |
| Product description: | Annexin I has been implicated in the regulation of phagocytosis, cell signaling and cell proliferation |
|---|---|
| Conjugation: | Unconjugated |
| Isotype: | IgG1 kappa |
| Molecular weight: | 32 |
| Immunogen: | Mixture of native membrane proteins from human bone tissues which would include whole native annexin proteins |
| Myeloma used: | Sp2/0-Ag14 |
| Target background: | Annexin I has been implicated in the regulation of phagocytosis, cell signaling and cell proliferation |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151030 | Anti-Progesterone [11P14] |
Key Info
Anti-Progesterone [11P14]
|
View Tool | |||||||||||||||||||
| 151024 | Anti-Hairy [1/24] |
Key Info
Anti-Hairy [1/24]
|
View Tool | |||||||||||||||||||
| 151027 | Anti-HSVICP8 [10A3] |
Key Info
Anti-HSVICP8 [10A3]
|
View Tool | |||||||||||||||||||
| 151029 | Anti-HSVICP8 [11E2] |
Key Info
Anti-HSVICP8 [11E2]
|
View Tool | |||||||||||||||||||
| 151033 | Anti-HSVUL42 [13C9] |
Key Info
Anti-HSVUL42 [13C9]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.